In contrast to the presented negative correlation of CTLA-4, PD-1, or PD-L1 with the long-term survival of AML patients [38,39,40,41], we provided evidence that those data do not exclude the scenario of a beneficial response to the applied chemotherapy. The gene discussed is PDCD1; the disease is acute myeloid leukemia.